RE: Introducing genesig complete2 Apr 2024 19:19
Hi Urraca , as far as we are aware, the June date still stands. The general consensus with LTH 's is a settlement agreed prior to June.
If there was any delay to the court date then they would have to issue an RNS ... which have been in short supply, to put it mildly!
Compared to many aim companies NCYT stands out because of its current cash position and we are all acutely aware of the plethora of companies who have struggled to raise and have consequently had to do so at ridiculous prices causing mass dilution.
It remains high risk .. but high gain potential also.
I still believe if it actually gets to court that Ncyt will win.
I haven't been phased by the leavers , except Paul Oladimeji and I personally don't think that was case related , think it was to do with the acquisition of Yourgene and the very different mgt style. Novacyt would have us believe that they 'run the show' looking at Yourgenes ex CEO and our interim CEO , I'm not so sure. I think he will give them all a wake up call, including Wakefield. Is that a good thing ? remains to be seen.
Think the shareholders have been treated appallingly, par for the course with aim.
No reason whatsoever imo that they couldn't make clear what their intentions are regarding a permanent CEO. If we win x will happen, if we lose then x will happen.
As to what R&D are working on , Gawd only knows, I certainly don't!
The information train stopped with GM's departure and we were fed a load of b/s about 100mm target , wasted time and money on a CEO who didn't cut the mustard and have never been proffered any form of explanation as to why he left or why the numbers ( approved by the CFO, now interim CEO) were so wildly inaccurate.
This is the last roll of the dice for me with Novacyt , I am more than fed up !
I still hold because I think we will win and that is the only reason. To even entertain not selling out the inf needs to start flowing and they need to crank up the RNS machine.